The US pharmaceutical industry has called for the reversal of a judicial ruling that could withdraw regulatory approval for a common abortion drug, arguing that the judgment would diminish the authority of government agencies and put the industry at risk.
美國制藥業呼吁撤銷一項司法裁決，這項裁決可能使對一種常見墮胎藥物的監管批準被撤回，美國制藥業認為該裁決將削弱政府機構的權威，并將該行業置于風險之中。
您已閱讀6%（329字），剩余94%（4886字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。